Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA.
We thank Monneret and Bonnefont-Rousselot for their commentary. Our controlled trial design overcomes most of their concerns of course; any failure of assay techniques would not have produced a biased result, but in fact would have decreased the chances of finding any between-group effects. In our s...
主要な著者: | Antoniades, C, Lee, R, Kohler, M, Stradling, J |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
European Respiratory Society
2016
|
類似資料
-
Overnight urinary isoprostane levels during CPAP withdrawal as a marker of oxidative stress
著者:: Turnbull, C, 等
出版事項: (2016) -
The effects of CPAP withdrawal in patients with OSA on hypoxia-induced markers
著者:: Turnbull, C, 等
出版事項: (2016) -
Effect of CPAP withdrawal on myocardial perfusion in OSA - a randomized controlled trial
著者:: Schwarz, E, 等
出版事項: (2016) -
Blood pressure variability in OSA – data from four randomised-controlled CPAP-withdrawal trials
著者:: Lettau, F, 等
出版事項: (2017) -
Effect of CPAP-withdrawal on blood pressure in OSA: data from three randomized-controlled trials
著者:: Schwarz, E, 等
出版事項: (2016)